Neuropsychiatric Disease and Treatment

ISSN: 1178-2021

Editor-in-Chief: Dr Roger M Pinder

1176-6328 (Print) - went to online only in 2009

An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Articles:

Latest articles:

- 5 records -

Original Research

Effectiveness of Vortioxetine in Working Patients with Major Depressive Disorder in China: A Subgroup Analysis of the RELIEVE China Study

Wang G, Si T, Rieckmann A, Ma J, Christensen MC

Neuropsychiatric Disease and Treatment 2024, 20:1211-1223

Published Date: 7 June 2024

Original Research

Abnormalities in Electroencephalographic Microstates in Patients with Late-Life Depression

Lao J, Zeng Y, Wu Z, Lin G, Wang Q, Yang M, Zhang S, Xu D, Zhang M, Yao K, Liang S, Liu Q, Li J, Zhong X, Ning Y

Neuropsychiatric Disease and Treatment 2024, 20:1201-1210

Published Date: 6 June 2024

Perspectives

Issues and Solutions in Psychiatric Clinical Trial with Case Studies

Chen X, Chen J, Zhao X, Mu R, Tan H, Yu Z

Neuropsychiatric Disease and Treatment 2024, 20:1191-1200

Published Date: 4 June 2024

Original Research

Cognition in Euthymic Patients with Bipolar Disorder: Do Not Forget to Account for Anxiety!

Yoldi-Negrete M, Fresán A, Jiménez-Rodríguez LI, Tirado-Durán EG

Neuropsychiatric Disease and Treatment 2024, 20:1181-1189

Published Date: 4 June 2024

Commentary

Implementing Interventions for Women and Youth with Traumatic Brain Injury at Transition from Custodial Settings: A Call to Action

Matheson FI, McLuhan A, Riccardi JS, Kirby A, McMillan TM

Neuropsychiatric Disease and Treatment 2024, 20:1169-1177

Published Date: 28 May 2024